Prediction: 3 Stocks That Will Be Worth More Than Palantir Technologies 5 Years From Now

In This Article:

Key Points

  • Intuitive Surgical is smaller than Palantir, but could be the bigger winner by the end of the decade.

  • Alibaba could widen its market cap gap with Palantir thanks to artificial intelligence (AI) tailwinds.

  • Google parent Alphabet's challenges shouldn't diminish its current huge size advantage over Palantir.

  • 10 stocks we like better than Alibaba Group ›

Few stocks have sizzled as much as Palantir Technologies (NASDAQ: PLTR) over the last 12 months. Shares of the data analytics software provider more than quadrupled during the period. Palantir stock is up more than 40% year to date.

However, Palantir isn't anywhere near the top of the list of stocks I think will be the biggest winners for investors over the long run. And some of those stocks could outperform through the rest of this decade, too. I predict three stocks will be worth more than Palantir five years from now.

1. Intuitive Surgical

Intuitive Surgical's (NASDAQ: ISRG) market cap is roughly $70 billion smaller than Palantir's right now. But I suspect the tables could be turned in the not-too-distant future.

Granted, Palantir is growing more rapidly. However, Intuitive Surgical continues to deliver impressive growth, too. The robotic systems pioneer's revenue jumped 19% year over year in the first quarter of 2025. Procedure volume for Intuitive's da Vinci robotic systems should increase by 15% to 17% this year.

Importantly, Intuitive Surgical looks like a bargain compared to Palantir. Sure, Intuitive's shares trade at a sky-high forward price-to-earnings ratio of 68. That seems almost cheap, though, when stacked up against Palantir's nosebleed forward earnings multiple of 196.

What I like most about Intuitive Surgical is the high probability of strong future growth. Around 2.7 million procedures were performed using da Vinci last year. Intuitive estimates roughly 8 million procedures are done annually for which it already has products and clearances. The company is targeting approximately 22 million soft-tissue procedures with products and clearances under development.

Healthcare professionals using a robotic surgical system.
Image source: Intuitive Surgical.

2. Alibaba Group

Alibaba Group (NYSE: BABA) is already somewhat larger than Palantir. Based on the two companies' recent revenue growth, though, some might think this dynamic could change relatively soon. I predict, though, that Alibaba will widen its market cap gap over Palantir over the next five years.

Valuation plays a big factor in my projection. We've already seen how mind-blowingly high Palantir's forward earnings multiple is. Meanwhile, Alibaba's shares trade at only 12.5 times forward earnings. The company's growth prospects make its valuation look even more attractive: Alibaba's price-to-earnings-to-growth (PEG) ratio based on analysts' five-year earnings projections is a low 0.71.